BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25417760)

  • 1. Risk factors for major depression during midlife among a community sample of women with and without prior major depression: are they the same or different?
    Bromberger JT; Schott L; Kravitz HM; Joffe H
    Psychol Med; 2015 Jun; 45(8):1653-64. PubMed ID: 25417760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of first lifetime episodes of major depression in midlife women.
    Bromberger JT; Kravitz HM; Matthews K; Youk A; Brown C; Feng W
    Psychol Med; 2009 Jan; 39(1):55-64. PubMed ID: 18377672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of depressive disorders across 13 years and their determinants among midlife women: SWAN mental health study.
    Bromberger JT; Kravitz HM; Youk A; Schott LL; Joffe H
    J Affect Disord; 2016 Dec; 206():31-40. PubMed ID: 27455356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN).
    Bromberger JT; Kravitz HM; Chang YF; Cyranowski JM; Brown C; Matthews KA
    Psychol Med; 2011 Sep; 41(9):1879-88. PubMed ID: 21306662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of family history of depression and the menopausal transition in the development of major depression in midlife women: Study of women's health across the nation mental health study (SWAN MHS).
    Colvin A; Richardson GA; Cyranowski JM; Youk A; Bromberger JT
    Depress Anxiety; 2017 Sep; 34(9):826-835. PubMed ID: 28489293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does family history of depression predict major depression in midlife women? Study of Women's Health Across the Nation Mental Health Study (SWAN MHS).
    Colvin A; Richardson GA; Cyranowski JM; Youk A; Bromberger JT
    Arch Womens Ment Health; 2014 Aug; 17(4):269-78. PubMed ID: 24952069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial features associated with lifetime comorbidity of major depression and anxiety disorders among a community sample of mid-life women: the SWAN mental health study.
    Cyranowski JM; Schott LL; Kravitz HM; Brown C; Thurston RC; Joffe H; Matthews KA; Bromberger JT
    Depress Anxiety; 2012 Dec; 29(12):1050-7. PubMed ID: 22930404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.
    Cohen LS; Soares CN; Vitonis AF; Otto MW; Harlow BL
    Arch Gen Psychiatry; 2006 Apr; 63(4):385-90. PubMed ID: 16585467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do anxiety symptoms predict major depressive disorder in midlife women? The Study of Women's Health Across the Nation (SWAN) Mental Health Study (MHS).
    Kravitz HM; Schott LL; Joffe H; Cyranowski JM; Bromberger JT
    Psychol Med; 2014 Sep; 44(12):2593-602. PubMed ID: 24467997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime depression history and sexual function in women at midlife.
    Cyranowski JM; Bromberger J; Youk A; Matthews K; Kravitz HM; Powell LH
    Arch Sex Behav; 2004 Dec; 33(6):539-48. PubMed ID: 15483368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does childhood maltreatment or current stress contribute to increased risk for major depression during the menopause transition?
    Bromberger JT; Chang Y; Colvin AB; Kravitz HM; Matthews KA
    Psychol Med; 2022 Oct; 52(13):2570-2577. PubMed ID: 33298219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study of neurotrophic, oxidative, and inflammatory markers in first-onset depression in midlife women.
    Pasquali MA; Harlow BL; Soares CN; Otto MW; Cohen LS; Minuzzi L; Gelain DP; Moreira JCF; Frey BN
    Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):771-781. PubMed ID: 28550365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partially distinct combinations of psychological, metabolic and inflammatory risk factors are prospectively associated with the onset of the subtypes of Major Depressive Disorder in midlife.
    Rudaz DA; Vandeleur CL; Gebreab SZ; Gholam-Rezaee M; Strippoli MF; Lasserre AM; Glaus J; Castelao E; Pistis G; von Känel R; Marques-Vidal P; Waeber G; Vollenweider P; Preisig M
    J Affect Disord; 2017 Nov; 222():195-203. PubMed ID: 28710953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifetime history of depression and anxiety disorders as a predictor of quality of life in midlife women in the absence of current illness episodes.
    Joffe H; Chang Y; Dhaliwal S; Hess R; Thurston R; Gold E; Matthews KA; Bromberger JT
    Arch Gen Psychiatry; 2012 May; 69(5):484-92. PubMed ID: 22566580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of depression in African American and Caucasian women at midlife: findings from the Study of Women Across the Nation (SWAN).
    Brown C; Bromberger JT; Schott LL; Crawford S; Matthews KA
    Arch Womens Ment Health; 2014 Dec; 17(6):549-57. PubMed ID: 24996377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Families at high and low risk for depression: a 3-generation study.
    Weissman MM; Wickramaratne P; Nomura Y; Warner V; Verdeli H; Pilowsky DJ; Grillon C; Bruder G
    Arch Gen Psychiatry; 2005 Jan; 62(1):29-36. PubMed ID: 15630070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset.
    Ongur D; Farabaugh A; Iosifescu DV; Perlis R; Fava M
    Psychother Psychosom; 2005; 74(3):173-8. PubMed ID: 15832068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study.
    Melartin TK; Haukka J; Rytsälä HJ; Jylhä PJ; Isometsä ET
    J Clin Psychiatry; 2010 Mar; 71(3):287-95. PubMed ID: 20079331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women.
    Kornstein SG; Clayton AH; Bao W; Guico-Pabia CJ
    J Womens Health (Larchmt); 2015 Apr; 24(4):281-90. PubMed ID: 25860107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.